Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | 321,203 | reported | 13 Nov 2017 | tx 3+235,384 |
| Traws Pharma, Inc. | 31,258 | reported | 08 Mar 2026 | tx 10+579,202−96,348 |
| ARQULE INC | 28,000 | reported | 19 May 2004 | tx 1+5,000 |
| Seres Therapeutics, Inc. | 15,000 | reported | 25 Jun 2015 | tx 1+15,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Mar 2026 | GRANT_AWARD | Traws Pharma, Inc. | 31,258 | 0.00 USD | deriv |
| 12 Dec 2025 | GRANT_AWARD | Traws Pharma, Inc. | 4,874 | 0.00 USD | |
| 12 Dec 2025 | GRANT_AWARD | Traws Pharma, Inc. | 19,496 | 0.00 USD | deriv |
| 12 Oct 2025 | GRANT_AWARD | Traws Pharma, Inc. | 11,530 | 0.00 USD | deriv |
| 19 Jun 2025 | GRANT_AWARD | Traws Pharma, Inc. | 23,000 | 0.00 USD | deriv |
| 18 Feb 2025 | EXERCISE | Traws Pharma, Inc. | 96,348 | 0.01 USD | |
| 18 Feb 2025 | EXERCISE | Traws Pharma, Inc. | 96,348 | 0.00 USD | deriv |
| 29 Dec 2024 | PURCHASE | Traws Pharma, Inc. | 96,348 | — | deriv |
| 29 Dec 2024 | PURCHASE | Traws Pharma, Inc. | 96,348 | — | derivfirst after silence |
| 01 Apr 2024 | GRANT_AWARD | Traws Pharma, Inc. | 200,000 | — | |
| 13 Nov 2017 | PURCHASE | Cartesian Therapeutics, Inc. | 20,000 | 9.31 USD | |
| 07 Jul 2017 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 21 Jun 2016 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 115,384 | 0.00 USD | deriv |
| 25 Jun 2015 | GRANT_AWARD | Seres Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 19 May 2004 | GRANT_AWARD | ARQULE INC | 5,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 29 Dec 2024.